1. Home
  2. CADL vs SAR Comparison

CADL vs SAR Comparison

Compare CADL & SAR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Candel Therapeutics Inc.

CADL

Candel Therapeutics Inc.

HOLD

Current Price

$5.04

Market Cap

357.4M

Sector

Health Care

ML Signal

HOLD

Logo Saratoga Investment Corp New

SAR

Saratoga Investment Corp New

HOLD

Current Price

$22.01

Market Cap

372.7M

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
CADL
SAR
Founded
1999
2007
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Investment Managers
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
357.4M
372.7M
IPO Year
2021
N/A

Fundamental Metrics

Financial Performance
Metric
CADL
SAR
Price
$5.04
$22.01
Analyst Decision
Strong Buy
Hold
Analyst Count
8
4
Target Price
$19.00
$23.75
AVG Volume (30 Days)
1.2M
113.7K
Earning Date
05-12-2026
05-06-2026
Dividend Yield
N/A
14.75%
EPS Growth
58.62
N/A
EPS
N/A
N/A
Revenue
$125,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$0.39
P/E Ratio
N/A
$9.44
Revenue Growth
N/A
N/A
52 Week Low
$4.25
$20.78
52 Week High
$7.24
$25.64

Technical Indicators

Market Signals
Indicator
CADL
SAR
Relative Strength Index (RSI) 49.25 47.13
Support Level $4.58 $21.40
Resistance Level $5.42 $23.41
Average True Range (ATR) 0.25 0.64
MACD 0.03 -0.02
Stochastic Oscillator 70.00 59.24

Price Performance

Historical Comparison
CADL
SAR

About CADL Candel Therapeutics Inc.

Candel Therapeutics Inc is a clinical stage biopharmaceutical company focused on developing off-the-shelf viral immunotherapies that elicit an individualized, systemic anti-tumor immune response to help patients fight cancer. The immune cells induced by these viral immunotherapies are believed to target patients' specific tumor antigens, potentially improving responses in immunologically hot tumors while at the same time infiltrating the tumor microenvironment, transforming non-inflamed cold tumors with limited immune response into hot tumors. The company has established two clinical off-the-shelf viral immunotherapy platforms based on novel, genetically modified adenovirus and herpes simplex virus (HSV) constructs, respectively.

About SAR Saratoga Investment Corp New

Saratoga Investment Corp is a specialty finance company that provides customized financing solutions to U.S. middle-market businesses. The Company invests in senior and unitranche leveraged loans and mezzanine debt, and, to a lesser extent, equity to provide financing for change of ownership transactions, strategic acquisitions, recapitalizations and growth initiatives in partnership with business owners, management teams and financial sponsors. Its objective is to create attractive risk-adjusted returns by generating current income and long-term capital appreciation from its debt and equity investments.

Share on Social Networks: